The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Radiotheranostic Market Research Report 2025

Global Radiotheranostic Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1735704

No of Pages : 114

Ask Your Query

Synopsis
Global Radiotheranostic market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Radiotheranostic market research.
Key companies engaged in the Radiotheranostic industry include ITM Isotopen Technologien München AG, Advanced Accelerator Applications, Telix Pharmaceuticals, Theragnostics Ltd., NuView Life Sciences, Jubilant Pharma Limited, Clarity Pharmaceuticals., TransCode Therapeutics, Inc. and Curium SAS, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Radiotheranostic were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Radiotheranostic market and estimated to attract more attentions from industry insiders and investors.

Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Radiotheranostic market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  • ITM Isotopen Technologien München AG
  • Advanced Accelerator Applications
  • Telix Pharmaceuticals
  • Theragnostics Ltd.
  • NuView Life Sciences
  • Jubilant Pharma Limited
  • Clarity Pharmaceuticals.
  • TransCode Therapeutics, Inc.
  • Curium SAS
  • GE Healthcare Inc.
  • Bayer AG
  • Lantheus Medical
  • Imaging, Inc.
  • Novartis AG
  • Spectrum Pharmaceuticals, Inc.
  • Ipsen S.A.
  • Actinium Pharmaceuticals, Inc. (ATNM)
  • Nordic Nanovector ASA
  • Y-mAbs Therapeutics, Inc.
  • Sofie Biosciences, Inc.
  • Terumo Corporation
  • Sirtex Medical Limited
  • Boston Scientific Corporation
  • Nihon Medi-Physics

Segment by Type

  • Nuclear Reactors
  • Cyclotrons

Segment by Application

  • Oncology
  • Non-Oncology

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia) 
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina, Colombia)

The Radiotheranostic report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source

Index

List of Tables
Table 1. Global Radiotheranostic Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Nuclear Reactors
Table 3. Key Players of Cyclotrons
Table 4. Global Radiotheranostic Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Radiotheranostic Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Radiotheranostic Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Radiotheranostic Market Share by Region (2018-2023)
Table 8. Global Radiotheranostic Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Radiotheranostic Market Share by Region (2024-2029)
Table 10. Radiotheranostic Market Trends
Table 11. Radiotheranostic Market Drivers
Table 12. Radiotheranostic Market Challenges
Table 13. Radiotheranostic Market Restraints
Table 14. Global Radiotheranostic Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Radiotheranostic Market Share by Players (2018-2023)
Table 16. Global Top Radiotheranostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiotheranostic as of 2022)
Table 17. Ranking of Global Top Radiotheranostic Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Radiotheranostic Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Radiotheranostic Product Solution and Service
Table 21. Date of Enter into Radiotheranostic Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Radiotheranostic Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Radiotheranostic Revenue Market Share by Type (2018-2023)
Table 25. Global Radiotheranostic Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Radiotheranostic Revenue Market Share by Type (2024-2029)
Table 27. Global Radiotheranostic Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Radiotheranostic Revenue Market Share by Application (2018-2023)
Table 29. Global Radiotheranostic Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Radiotheranostic Revenue Market Share by Application (2024-2029)
Table 31. North America Radiotheranostic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Radiotheranostic Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Radiotheranostic Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Radiotheranostic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Radiotheranostic Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Radiotheranostic Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Radiotheranostic Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Radiotheranostic Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Radiotheranostic Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Radiotheranostic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Radiotheranostic Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Radiotheranostic Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Radiotheranostic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Radiotheranostic Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Radiotheranostic Market Size by Country (2024-2029) & (US$ Million)
Table 46. ITM Isotopen Technologien München AG Company Detail
Table 47. ITM Isotopen Technologien München AG Business Overview
Table 48. ITM Isotopen Technologien München AG Radiotheranostic Product
Table 49. ITM Isotopen Technologien München AG Revenue in Radiotheranostic Business (2018-2023) & (US$ Million)
Table 50. ITM Isotopen Technologien München AG Recent Development
Table 51. Advanced Accelerator Applications Company Detail
Table 52. Advanced Accelerator Applications Business Overview
Table 53. Advanced Accelerator Applications Radiotheranostic Product
Table 54. Advanced Accelerator Applications Revenue in Radiotheranostic Business (2018-2023) & (US$ Million)
Table 55. Advanced Accelerator Applications Recent Development
Table 56. Telix Pharmaceuticals Company Detail
Table 57. Telix Pharmaceuticals Business Overview
Table 58. Telix Pharmaceuticals Radiotheranostic Product
Table 59. Telix Pharmaceuticals Revenue in Radiotheranostic Business (2018-2023) & (US$ Million)
Table 60. Telix Pharmaceuticals Recent Development
Table 61. Theragnostics Ltd. Company Detail
Table 62. Theragnostics Ltd. Business Overview
Table 63. Theragnostics Ltd. Radiotheranostic Product
Table 64. Theragnostics Ltd. Revenue in Radiotheranostic Business (2018-2023) & (US$ Million)
Table 65. Theragnostics Ltd. Recent Development
Table 66. NuView Life Sciences Company Detail
Table 67. NuView Life Sciences Business Overview
Table 68. NuView Life Sciences Radiotheranostic Product
Table 69. NuView Life Sciences Revenue in Radiotheranostic Business (2018-2023) & (US$ Million)
Table 70. NuView Life Sciences Recent Development
Table 71. Jubilant Pharma Limited Company Detail
Table 72. Jubilant Pharma Limited Business Overview
Table 73. Jubilant Pharma Limited Radiotheranostic Product
Table 74. Jubilant Pharma Limited Revenue in Radiotheranostic Business (2018-2023) & (US$ Million)
Table 75. Jubilant Pharma Limited Recent Development
Table 76. Clarity Pharmaceuticals. Company Detail
Table 77. Clarity Pharmaceuticals. Business Overview
Table 78. Clarity Pharmaceuticals. Radiotheranostic Product
Table 79. Clarity Pharmaceuticals. Revenue in Radiotheranostic Business (2018-2023) & (US$ Million)
Table 80. Clarity Pharmaceuticals. Recent Development
Table 81. TransCode Therapeutics, Inc. Company Detail
Table 82. TransCode Therapeutics, Inc. Business Overview
Table 83. TransCode Therapeutics, Inc. Radiotheranostic Product
Table 84. TransCode Therapeutics, Inc. Revenue in Radiotheranostic Business (2018-2023) & (US$ Million)
Table 85. TransCode Therapeutics, Inc. Recent Development
Table 86. Curium SAS Company Detail
Table 87. Curium SAS Business Overview
Table 88. Curium SAS Radiotheranostic Product
Table 89. Curium SAS Revenue in Radiotheranostic Business (2018-2023) & (US$ Million)
Table 90. Curium SAS Recent Development
Table 91. GE Healthcare Inc. Company Detail
Table 92. GE Healthcare Inc. Business Overview
Table 93. GE Healthcare Inc. Radiotheranostic Product
Table 94. GE Healthcare Inc. Revenue in Radiotheranostic Business (2018-2023) & (US$ Million)
Table 95. GE Healthcare Inc. Recent Development
Table 96. Bayer AG Company Detail
Table 97. Bayer AG Business Overview
Table 98. Bayer AG Radiotheranostic Product
Table 99. Bayer AG Revenue in Radiotheranostic Business (2018-2023) & (US$ Million)
Table 100. Bayer AG Recent Development
Table 101. Lantheus Medical Company Detail
Table 102. Lantheus Medical Business Overview
Table 103. Lantheus Medical Radiotheranostic Product
Table 104. Lantheus Medical Revenue in Radiotheranostic Business (2018-2023) & (US$ Million)
Table 105. Lantheus Medical Recent Development
Table 106. Imaging, Inc. Company Detail
Table 107. Imaging, Inc. Business Overview
Table 108. Imaging, Inc. Radiotheranostic Product
Table 109. Imaging, Inc. Revenue in Radiotheranostic Business (2018-2023) & (US$ Million)
Table 110. Imaging, Inc. Recent Development
Table 111. Novartis AG Company Detail
Table 112. Novartis AG Business Overview
Table 113. Novartis AG Radiotheranostic Product
Table 114. Novartis AG Revenue in Radiotheranostic Business (2018-2023) & (US$ Million)
Table 115. Novartis AG Recent Development
Table 116. Spectrum Pharmaceuticals, Inc. Company Detail
Table 117. Spectrum Pharmaceuticals, Inc. Business Overview
Table 118. Spectrum Pharmaceuticals, Inc. Radiotheranostic Product
Table 119. Spectrum Pharmaceuticals, Inc. Revenue in Radiotheranostic Business (2018-2023) & (US$ Million)
Table 120. Spectrum Pharmaceuticals, Inc. Recent Development
Table 121. Ipsen S.A. Company Detail
Table 122. Ipsen S.A. Business Overview
Table 123. Ipsen S.A. Radiotheranostic Product
Table 124. Ipsen S.A. Revenue in Radiotheranostic Business (2018-2023) & (US$ Million)
Table 125. Ipsen S.A. Recent Development
Table 126. Actinium Pharmaceuticals, Inc. (ATNM) Company Detail
Table 127. Actinium Pharmaceuticals, Inc. (ATNM) Business Overview
Table 128. Actinium Pharmaceuticals, Inc. (ATNM) Radiotheranostic Product
Table 129. Actinium Pharmaceuticals, Inc. (ATNM) Revenue in Radiotheranostic Business (2018-2023) & (US$ Million)
Table 130. Actinium Pharmaceuticals, Inc. (ATNM) Recent Development
Table 131. Nordic Nanovector ASA Company Detail
Table 132. Nordic Nanovector ASA Business Overview
Table 133. Nordic Nanovector ASA Radiotheranostic Product
Table 134. Nordic Nanovector ASA Revenue in Radiotheranostic Business (2018-2023) & (US$ Million)
Table 135. Nordic Nanovector ASA Recent Development
Table 136. Y-mAbs Therapeutics, Inc. Company Detail
Table 137. Y-mAbs Therapeutics, Inc. Business Overview
Table 138. Y-mAbs Therapeutics, Inc. Radiotheranostic Product
Table 139. Y-mAbs Therapeutics, Inc. Revenue in Radiotheranostic Business (2018-2023) & (US$ Million)
Table 140. Y-mAbs Therapeutics, Inc. Recent Development
Table 141. Sofie Biosciences, Inc. Company Detail
Table 142. Sofie Biosciences, Inc. Business Overview
Table 143. Sofie Biosciences, Inc. Radiotheranostic Product
Table 144. Sofie Biosciences, Inc. Revenue in Radiotheranostic Business (2018-2023) & (US$ Million)
Table 145. Sofie Biosciences, Inc. Recent Development
Table 146. Terumo Corporation Company Detail
Table 147. Terumo Corporation Business Overview
Table 148. Terumo Corporation Radiotheranostic Product
Table 149. Terumo Corporation Revenue in Radiotheranostic Business (2018-2023) & (US$ Million)
Table 150. Terumo Corporation Recent Development
Table 151. Sirtex Medical Limited Company Detail
Table 152. Sirtex Medical Limited Business Overview
Table 153. Sirtex Medical Limited Radiotheranostic Product
Table 154. Sirtex Medical Limited Revenue in Radiotheranostic Business (2018-2023) & (US$ Million)
Table 155. Sirtex Medical Limited Recent Development
Table 156. Boston Scientific Corporation Company Detail
Table 157. Boston Scientific Corporation Business Overview
Table 158. Boston Scientific Corporation Radiotheranostic Product
Table 159. Boston Scientific Corporation Revenue in Radiotheranostic Business (2018-2023) & (US$ Million)
Table 160. Boston Scientific Corporation Recent Development
Table 161. Nihon Medi-Physics Company Detail
Table 162. Nihon Medi-Physics Business Overview
Table 163. Nihon Medi-Physics Radiotheranostic Product
Table 164. Nihon Medi-Physics Revenue in Radiotheranostic Business (2018-2023) & (US$ Million)
Table 165. Nihon Medi-Physics Recent Development
Table 166. Research Programs/Design for This Report
Table 167. Key Data Information from Secondary Sources
Table 168. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Radiotheranostic Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Radiotheranostic Market Share by Type: 2022 VS 2029
Figure 3. Nuclear Reactors Features
Figure 4. Cyclotrons Features
Figure 5. Global Radiotheranostic Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Radiotheranostic Market Share by Application: 2022 VS 2029
Figure 7. Oncology Case Studies
Figure 8. Non-Oncology Case Studies
Figure 9. Radiotheranostic Report Years Considered
Figure 10. Global Radiotheranostic Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 11. Global Radiotheranostic Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Radiotheranostic Market Share by Region: 2022 VS 2029
Figure 13. Global Radiotheranostic Market Share by Players in 2022
Figure 14. Global Top Radiotheranostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiotheranostic as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by Radiotheranostic Revenue in 2022
Figure 16. North America Radiotheranostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 17. North America Radiotheranostic Market Share by Country (2018-2029)
Figure 18. United States Radiotheranostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. Canada Radiotheranostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Europe Radiotheranostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Radiotheranostic Market Share by Country (2018-2029)
Figure 22. Germany Radiotheranostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. France Radiotheranostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. U.K. Radiotheranostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Italy Radiotheranostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Russia Radiotheranostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Nordic Countries Radiotheranostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Asia-Pacific Radiotheranostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Radiotheranostic Market Share by Region (2018-2029)
Figure 30. China Radiotheranostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Japan Radiotheranostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. South Korea Radiotheranostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Southeast Asia Radiotheranostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. India Radiotheranostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Australia Radiotheranostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Latin America Radiotheranostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Radiotheranostic Market Share by Country (2018-2029)
Figure 38. Mexico Radiotheranostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Brazil Radiotheranostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Middle East & Africa Radiotheranostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Radiotheranostic Market Share by Country (2018-2029)
Figure 42. Turkey Radiotheranostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Saudi Arabia Radiotheranostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. ITM Isotopen Technologien München AG Revenue Growth Rate in Radiotheranostic Business (2018-2023)
Figure 45. Advanced Accelerator Applications Revenue Growth Rate in Radiotheranostic Business (2018-2023)
Figure 46. Telix Pharmaceuticals Revenue Growth Rate in Radiotheranostic Business (2018-2023)
Figure 47. Theragnostics Ltd. Revenue Growth Rate in Radiotheranostic Business (2018-2023)
Figure 48. NuView Life Sciences Revenue Growth Rate in Radiotheranostic Business (2018-2023)
Figure 49. Jubilant Pharma Limited Revenue Growth Rate in Radiotheranostic Business (2018-2023)
Figure 50. Clarity Pharmaceuticals. Revenue Growth Rate in Radiotheranostic Business (2018-2023)
Figure 51. TransCode Therapeutics, Inc. Revenue Growth Rate in Radiotheranostic Business (2018-2023)
Figure 52. Curium SAS Revenue Growth Rate in Radiotheranostic Business (2018-2023)
Figure 53. GE Healthcare Inc. Revenue Growth Rate in Radiotheranostic Business (2018-2023)
Figure 54. Bayer AG Revenue Growth Rate in Radiotheranostic Business (2018-2023)
Figure 55. Lantheus Medical Revenue Growth Rate in Radiotheranostic Business (2018-2023)
Figure 56. Imaging, Inc. Revenue Growth Rate in Radiotheranostic Business (2018-2023)
Figure 57. Novartis AG Revenue Growth Rate in Radiotheranostic Business (2018-2023)
Figure 58. Spectrum Pharmaceuticals, Inc. Revenue Growth Rate in Radiotheranostic Business (2018-2023)
Figure 59. Ipsen S.A. Revenue Growth Rate in Radiotheranostic Business (2018-2023)
Figure 60. Actinium Pharmaceuticals, Inc. (ATNM) Revenue Growth Rate in Radiotheranostic Business (2018-2023)
Figure 61. Nordic Nanovector ASA Revenue Growth Rate in Radiotheranostic Business (2018-2023)
Figure 62. Y-mAbs Therapeutics, Inc. Revenue Growth Rate in Radiotheranostic Business (2018-2023)
Figure 63. Sofie Biosciences, Inc. Revenue Growth Rate in Radiotheranostic Business (2018-2023)
Figure 64. Terumo Corporation Revenue Growth Rate in Radiotheranostic Business (2018-2023)
Figure 65. Sirtex Medical Limited Revenue Growth Rate in Radiotheranostic Business (2018-2023)
Figure 66. Boston Scientific Corporation Revenue Growth Rate in Radiotheranostic Business (2018-2023)
Figure 67. Nihon Medi-Physics Revenue Growth Rate in Radiotheranostic Business (2018-2023)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock